Partners In Investing

With liquid alternatives, investors don’t have to choose between return, diversification, and liquidity. GMO explains how ALTA strives to achieve all three.

GMO's 7-Year Asset Class Forecast as of July 31, 2026.

What creates a durable edge in systematic equity investing? GMO examines the research, valuation framework, and portfolio construction behind its approach.

As the Goldilocks era ends, liquidity and true diversification matter more. GMO explores why liquid alternatives deserve a fresh look.

Surging electricity demand is reshaping the energy landscape, creating opportunities for investors across a wide variety of industries.

In GMO’s latest Quarterly Valuation Update, FX and local currency rates screen cheap and very cheap, while hard currency credit is rich.

GMO's 7-Year Asset Class Forecast as of June 30, 2026.

Emerging market debt is broad and inefficient. We examine when a total return, cash‑plus approach may better align portfolios with desired outcomes.

GMO's Equity Dislocation Strategy has gotten off to a strong start in H1 2026. Our mid-year update explores how valuation discipline and active rotation shaped performance amid AI-driven volatility.

Japan’s corporate governance reforms are entering a new phase aimed squarely at how companies put capital to work. We examine what that means for investors and why active engagement still matters.

Structural reforms, rising earnings, and attractive valuations suggest Japanese equities still offer meaningful upside despite strong recent returns.

Many still treat 60/40 as a neutral starting point. But after years of market gains, that “default” mix can embed unintended concentration in expensive U.S. growth and credit risk with limited spread cushion.